Anthony Caggiano - 15 Feb 2024 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
Chief Medical Officer
Signature
/s/ Lisa Ricciardi, Attorney-in-Fact
Issuer symbol
CGTX
Transactions as of
15 Feb 2024
Transactions value $
$0
Form type
4
Filing time
20 Feb 2024, 16:13:22 UTC
Previous filing
09 Feb 2024
Next filing
04 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGTX Common Stock Award $0 +60,000 +74% $0 141,629 15 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGTX Stock Option (Right to Buy) Award $0 +60,000 $0 60,000 15 Feb 2024 Common Stock 60,000 $1.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F2 The option vests 25% on February 15, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.

Remarks:

Exhibit 24 - Power of Attorney